Roche Holding (RNA Therapeutics Business) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Roche Holding (RNA Therapeutics Business) General Information

Description

Developer of nucleic acid based technologies and products. The company is engaged in developing of prescription drugs.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Madison, WI
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Roche Holding (RNA Therapeutics Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Roche Holding (RNA Therapeutics Business)‘s full profile, request access.

Request a free trial

Roche Holding (RNA Therapeutics Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Roche Holding (RNA Therapeutics Business)‘s full profile, request access.

Request a free trial

Roche Holding (RNA Therapeutics Business) FAQs

  • Where is Roche Holding (RNA Therapeutics Business) headquartered?

    Roche Holding (RNA Therapeutics Business) is headquartered in Madison, WI.

  • What industry is Roche Holding (RNA Therapeutics Business) in?

    Roche Holding (RNA Therapeutics Business)’s primary industry is Drug Delivery.

  • Is Roche Holding (RNA Therapeutics Business) a private or public company?

    Roche Holding (RNA Therapeutics Business) is a Private company.

  • What is the current valuation of Roche Holding (RNA Therapeutics Business)?

    The current valuation of Roche Holding (RNA Therapeutics Business) is 00.00.

  • What is Roche Holding (RNA Therapeutics Business)’s current revenue?

    The current revenue for Roche Holding (RNA Therapeutics Business) is 000000.

  • Who are Roche Holding (RNA Therapeutics Business)’s investors?

    Roche has invested in Roche Holding (RNA Therapeutics Business).

  • When was Roche Holding (RNA Therapeutics Business) acquired?

    Roche Holding (RNA Therapeutics Business) was acquired on 24-Oct-2011.

  • Who acquired Roche Holding (RNA Therapeutics Business)?

    Roche Holding (RNA Therapeutics Business) was acquired by Arrowhead Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »